Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,397 | -25,950 | -9,242 | -10,446 | -6,051 |
| Depreciation Amortization | 5,976 | 720 | 116 | 54 | 28 |
| Income taxes - deferred | -831 | -303 | N/A | N/A | N/A |
| Accounts receivable | 99 | 572 | -4 | -35 | -9 |
| Other Working Capital | -2,996 | 2,969 | 482 | -352 | -112 |
| Other Operating Activity | 8,673 | 13,620 | 3,916 | 4,647 | 2,506 |
| Operating Cash Flow | $-8,477 | $-8,372 | $-4,732 | $-6,132 | $-3,639 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 318 | N/A | N/A | N/A | N/A |
| PPE Investments | -16,378 | -2,388 | -10 | -118 | -43 |
| Other Investing Activity | -1,046 | -263 | 0 | 271 | 0 |
| Investing Cash Flow | $-17,106 | $-2,651 | $-10 | $153 | $-43 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 20,507 | 2,918 | 132 | 337 | 180 |
| Debt Issued | 3,000 | 1,954 | N/A | N/A | 250 |
| Debt Repayment | -1,637 | -15 | -25 | -21 | -21 |
| Common Stock Issued | 24,315 | N/A | 2,899 | 7,939 | 3,573 |
| Dividend Paid | -223 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -12,106 | 12,927 | -136 | -409 | -353 |
| Financing Cash Flow | $33,856 | $17,784 | $2,869 | $7,847 | $3,630 |
| Exchange Rate Effect | 180 | -32 | N/A | N/A | N/A |
| Beginning Cash Position | 7,159 | 431 | 2,304 | 437 | 489 |
| End Cash Position | 15,612 | 7,159 | 431 | 2,304 | 437 |
| Net Cash Flow | $8,453 | $6,729 | $-1,873 | $1,868 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,477 | -8,372 | -4,732 | -6,132 | -3,639 |
| Capital Expenditure | -16,378 | -2,388 | -10 | -118 | -43 |
| Free Cash Flow | -24,854 | -10,760 | -4,742 | -6,250 | -3,682 |